Latest News
Closing the Health Gap
On the Iternational Women's Day we want to address the THE WOMEN’S HEALTH GAP
Gedea wins prestigious scale up award
On Thursday November 28th, at the Nordic Mentor Network For Entrepreneurship - NOME annual meeting in Copenhagen, we were honored to receive the…
Emilia, industrial doctoral student at Gedea and Karolinska Institutet
Emilia Lahtinen is an industrial Ph.D. student at Gedea and at Karolinska Institutet. Her project has the title Bacterial vaginosis: Understanding…
Anna-Karin Areskog strengthens the team
Gedea has recently strengthened its team by hiring Anna-Karin Areskog as QA Director. Anna-Karin has been a consultant with the company since April…
Gedea´s share issue oversubscribed by 54%
Gedea Biotech AB carried out a rights issue of SEK 24.3 million during October. The interest from both existing owners and new investors exceeded the…
Per-Ola Forsberg new CFO at Gedea
We are pleased to announce that Per-Ola Forsberg has been appointed as the new CFO of Gedea since April 20th. Per-Ola holds a degree in business…
About pHyph
pHyph is a CE-marked, antibiotic-free vaginal tablet approved under the EU Medical Device Regulation (MDR) for the treatment of bacterial vaginosis (BV) and for promoting a healthy vaginal microbiome. By restoring the vaginal environment and supporting beneficial lactobacilli, pHyph provides an innovative alternative to conventional treatments. The product is developed by Gedea Biotech to address a significant unmet need for safe and effective treatments that support long-term vaginal health.
About Gedea Biotech
Gedea Biotech AB is a Swedish women’s health company on a mission to make a sustainable impact to global women’s health with a modern, antibiotic-free treatment for common vaginal infections that women can trust for long-term effect, available when they need it. Its lead product pHyph is CE-marked under the EU Medical Device Regulation (MDR) for the treatment of bacterial vaginosis and promotion of a healthy vaginal microbiome. Gedea is a spin out from Lund University and is based in Lund, Sweden.
Supported by the European Innovation Council
The European Innovation Council is Europe’s flagship innovation programme to identify, develop and scale up breakthrough technologies and game changing innovations The EIC has been established under the EU programme. It has a budget of €10.1 billion to support game changing innovations throughout the lifecycle from early stage research, to proof of concept, technology transfer, and the financing and scale up of start-ups and SMEs.
Press Kit
Click to download logos and images.
